Article
Myasthenia gravis: The pharmacological basis of traditional Chinese medicine for its clinical application
18 Dec 2021
Abstract excerpt
We aimed to investigate the target and signal pathway of Smilacis Glabrae Rhixoma (SGR) in the treatment of myasthenia gravis (MG) based on network pharmacology, and to explore its potential molecular mechanism. The main active components of SGR were searched in the pharmacology database of traditional Chinese medicine systems, and analysis platform. The related targets of SGR were obtained by Genecards,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
